Laboratory Corporation of America Holdings Stock
Equities
LH
US50540R4092
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
210.4 USD | +1.30% | +4.64% | -7.44% |
Financials (USD)
Sales 2024 * | 12.81B | Sales 2025 * | 13.43B | Capitalization | 17.51B |
---|---|---|---|---|---|
Net income 2024 * | 982M | Net income 2025 * | 1.11B | EV / Sales 2024 * | 1.74 x |
Net Debt 2024 * | 4.82B | Net Debt 2025 * | 4B | EV / Sales 2025 * | 1.6 x |
P/E ratio 2024 * |
17.9
x | P/E ratio 2025 * |
15.9
x | Employees | 61,975 |
Yield 2024 * |
1.41% | Yield 2025 * |
1.45% | Free-Float | 99.65% |
Latest transcript on Laboratory Corporation of America Holdings
1 day | +1.30% | ||
1 week | +4.64% | ||
Current month | +4.47% | ||
1 month | +2.26% | ||
3 months | -5.80% | ||
6 months | +2.92% | ||
Current year | -7.44% |
Managers | Title | Age | Since |
---|---|---|---|
Adam Schechter
CEO | Chief Executive Officer | 59 | 13-03-31 |
Glenn Eisenberg
DFI | Director of Finance/CFO | 63 | 14-06-15 |
Compliance Officer | 65 | 19-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Williams
BRD | Director/Board Member | 75 | 07-05-15 |
Adam Schechter
CEO | Chief Executive Officer | 59 | 13-03-31 |
Director/Board Member | 74 | 95-04-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.97% | 2 M€ | +9.27% | ||
1.95% | 8 M€ | +4.88% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 210.4 | +1.30% | 792,843 |
24-05-10 | 207.7 | +0.74% | 722,931 |
24-05-09 | 206.2 | +2.25% | 813,688 |
24-05-08 | 201.6 | +0.05% | 556,886 |
24-05-07 | 201.5 | +0.23% | 620,897 |
Delayed Quote Nyse, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.44% | 17.51B | |
+17.18% | 85.55B | |
-28.48% | 70.07B | |
+6.76% | 28.95B | |
+2.14% | 17.39B | |
+2.10% | 15.38B | |
+7.02% | 13.4B | |
+64.96% | 12.93B | |
+6.64% | 12.77B | |
+66.89% | 12.42B |
- Stock Market
- Equities
- LH Stock